In this study, we identified salt‐inducible kinase 2 (SIK2), a serine/threonine kinase of the AMPK subfamily,11 as a novel kinase associated with radioresistance in CRC through a kinase‐targeted CRISPR‐Cas9 screen. Here, SIK2 is linked to colorectal carcinoma.